Publication | Closed Access

A novel role of andrographolide, an NF-kappa B inhibitor, on inhibition of platelet activation: the pivotal mechanisms of endothelial nitric oxide synthase/cyclic GMP

InflammationThrombosisThrombopoiesisCardiovascular DiseaseBlood PlateletAtherosclerosisMedicineImmunologyEndothelial DysfunctionNovel RoleVascular BiologyPlatelet AntagonistPharmacologyCell BiologyCell SignalingNf-kappa B InhibitorPlatelet Activation